ZMIZ1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.407580E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.741500E-02
Normal-vs-Stage2
7.52170000000163E-05
Normal-vs-Stage3
2.106000E-02
Normal-vs-Stage4
5.770100E-02
Stage1-vs-Stage2
4.160000E-01
Stage1-vs-Stage3
2.518800E-01
Stage1-vs-Stage4
9.790600E-01
Stage2-vs-Stage3
3.387800E-01
Stage2-vs-Stage4
4.822600E-01
Stage3-vs-Stage4
3.067600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.039860E-04
Normal-vs-AfricanAmerican
3.042100E-02
Normal-vs-Asian
2.075600E-02
Caucasian-vs-AfricanAmerican
4.355600E-01
Caucasian-vs-Asian
8.390400E-01
AfricanAmerican-vs-Asian
6.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.646000E-04
Normal-vs-Female
5.81600000000293E-05
Male-vs-Female
9.709800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.634500E-02
Normal-vs-Age(41-60Yrs)
8.602900E-04
Normal-vs-Age(61-80Yrs)
1.442560E-04
Normal-vs-Age(81-100Yrs)
2.397500E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.955000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.630600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.854400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.477700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.760250E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.689200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.407300E-04
Normal-vs-Daily Drinker
2.629400E-04
Normal-vs-Weekly Drinker
4.498500E-03
Normal-vs-Occasional Drinker
7.715000E-03
Normal-vs-Social Drinker
5.478400E-03
Non Drinker-vs-Daily Drinker
8.432800E-01
Non Drinker-vs-Weekly Drinker
2.429400E-01
Non Drinker-vs-Occasional Drinker
1.288990E-01
Non Drinker-vs-Social Drinker
1.229220E-01
Daily Drinker-vs-Weekly Drinker
1.974010E-01
Daily Drinker-vs-Occasional Drinker
1.090570E-01
Daily Drinker-vs-Social Drinker
9.923800E-02
Weekly Drinker-vs-Occasional Drinker
7.970800E-01
Weekly Drinker-vs-Social Drinker
7.611600E-01
Occasional Drinker-vs-Social Drinker
9.672200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.138500E-02
Normal-vs-Grade 2
6.916200E-03
Normal-vs-Grade 3
1.469540E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.512000E-01
Grade 1-vs-Grade 3
5.481400E-01
Grade 1-vs-Grade 4
7.138500E-02
Grade 2-vs-Grade 3
4.627200E-01
Grade 2-vs-Grade 4
6.916200E-03
Grade 3-vs-Grade 4
1.469540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.759000E-04
Normal-vs-NonDiabetic
2.429700E-04
Diabetic-vs-NonDiabetic
3.058400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.445700E-04
Normal-vs-NoPancreatitis
2.769600E-04
Pancreatitis-vs-NoPancreatitis
4.427000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.441100E-04
Normal-vs-N1
1.191240E-04
N0-vs-N1
8.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.56800000000224E-05
Normal-vs-TP53-NonMutant
5.083600E-03
TP53-Mutant-vs-TP53-NonMutant
1.464830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
